Why cancer drug development has to involve patient voices
Cancer drug development clinical trials

Why cancer drug development has to involve patient voices

Dr. Talia Henkle
Dr. Talia Henkle

In 10 seconds? Meaningful measures of patient experiences have been conspicuously absent from cancer clinical trial data. The time has come to elevate patient voices in the treatment approval process.

I’m confused. How can patient voices be absent? Let me put the current process into perspective. Drug development is a strategic business. For a new cancer treatment to be authorized for use, it must be approved by a regulatory agency (such as the FDA in the US or the EMA in Europe). Pharma companies burn large sums to develop drugs and fund carefully crafted clinical trials, to prove to the FDA and others that their treatment serves an unmet medical need.

Get unlimited access to our 3-min Digests and other premium features!

Choose your plan.

Sparrow Insiders

$0 (Limited Offer)
  • Receive our daily Digest in your inbox
  • Created & reviewed by real scientists
  • Preview 380+ Digests in our library
  • Upgrade for unlimited learning
  • Unsubscribe anytime
  • Subject to availability
Join our first 25k subscribers for free! Signup Progress Bar Subscribe now for free

Sparrow Unlimited

$19 / month
  • Talk with our scientists and ask them anything
  • Access 380+ summaries anywhere, anytime
  • Listen to our premium podcast
  • Weekly newsletter of the top 5 scientific findings
  • Daily updates with new content
  • Support independent science publishing
  • No advertisement
  • Cancel anytime
Learn more Subscribe now

Sparrow Unlimited

$99 / year
  • One easy payment - save 56%
  • Talk with our scientists and ask them anything
  • Access 380+ summaries anywhere, anytime
  • Listen to our premium podcast
  • Weekly newsletter of the top 5 scientific findings
  • Daily updates with new content
  • Support independent science publishing
  • No advertisement
  • Cancel anytime
Learn more Subscribe now